The Gladstone Institutes explored two different paths to expand its footprint in Mission Bay, ultimately choosing a lease ...
A Bay Area biotech company saw its obesity drug fail in clinical trials just five months ago. Now it's being acquired for nearly $7 billion after shifting its focus to a different disease.
The decision U.S. President Donald Trump made to attack Iran was a high-stakes gamble. The gamble is not really in the military campaign itself, which is unfolding in jaw-droppingly competent fashion.